GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.1% ·
Aktienfluss +4.9% ·
neue Nettopositionen +6.7%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 10.13M | +188.6% | $232.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 10.13M | +188.6% | $232.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 10.13M | +188.6% | $232.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 10.13M | +188.6% | $232.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 5.87M | -3.6% | $134.70M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 5.87M | -3.6% | $134.70M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 5.87M | -3.6% | $134.70M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 5.87M | -3.6% | $134.70M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 2.82M | +1.1% | $64.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 2.82M | +1.1% | $64.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | ARK Investment Management ✦ | 1.51M | +233.5% | $34.70M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.37M | +67.6% | $31.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (passiv) | 1.18M | -14.8% | $27.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 842.51K | -38.8% | $19.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 842.51K | -38.8% | $19.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 653.98K | -69.4% | $15.00M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 438.40K | Neu | $10.06M | 0.0% | New | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 330.40K | -90.0% | $7.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 66.18K | 0.0% | $1.52M | 0.0% | Held | 2 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 56.80K | -81.0% | $1.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 18.14K | -10.2% | $416,132 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 15.18K | -82.1% | $348,183 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 12.44K | Neu | $284,513 | 0.0% | New | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 12.44K | Neu | $284,513 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Renaissance Technologies | $10.06M | 0.0% |
| AQR Capital Management | $284,513 | 0.0% |
| AQR Capital Management | $284,513 | 0.0% |
Ausgestiegen
| Point72 Asset Management | $52.42M | war 0.2% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 481 Inhaber, 137.05M Anteile, $11.53B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 20.89K Ant. · $3.53M
Officer, Director · 7.59K Ant. · $1.29M
Officer, Director · 9.02K Ant. · $1.52M
Director · 116 Ant. · $18,148
Officer · 13.25K Ant. · $2.20M
Officer · 3.70K Ant. · $605,286
Officer · 9.93K Ant. · $1.63M
Officer · 19.01K Ant. · $3.14M
Officer · 400 Ant. · $67,168
Officer · 3.46K Ant. · $579,639
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik